Michael Fucci, MD
Otology & Neurotology · Chandler, AZNPI 1174510556
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (53.3%), travel and lodging and education — rather than concentrated in one kind of arrangement. 6 manufacturers reported payments, led by Medical Device Business Services, Inc. at 52.2% of the total. Reporting peaked in 2022 at $390 and has fallen 89.0% since, to $43 in 2025.
Across 22 payments — averaging $32.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$377
- Advanced Bionics, LLC$126
- Cochlear Americas$111
- Med-el Corporation$69
- Travere Therapeutics, Inc.$25
- Bausch & Lomb Americas Inc.$14
What the payments were for
- Travel & lodging$30843%
- Food & beverage$38653%
- Education$253%
- Gifts$41%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 5 | $377 |
| Advanced Bionics, LLC | 5 | $126 |
| Cochlear Americas | 4 | $111 |
| Med-el Corporation | 3 | $69 |
| Travere Therapeutics, Inc. | 4 | $25 |
| Bausch & Lomb Americas Inc. | 1 | $14 |
How this compares
Too few otology & neurotology providers in Arizonato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 24 | $2,352 |
| Ciprofloxacin Hcl | 92 | $1,553 |
| Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort | 19 | $1,149 |
| Ipratropium Bromide | 24 | $972 |
| Acetic Acid | 27 | $496 |
| Azelastine Hcl | 15 | $290 |
| Cephalexin | 47 | $266 |
| Mometasone Furoate | 12 | $201 |
| Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid | 15 | $189 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 42 | $177 |
| Ondansetron OdtOndansetron | 15 | $105 |
| Spironolactone | 22 | $101 |
| Diazepam | 13 | $96 |
| Methylprednisolone | 17 | $89 |
| Ondansetron Hcl | 34 | $68 |
Paid to pharmacies, not to this prescriber.
Other otology & neurotology in Chandler
- Adam CassisChandler$6K
- Abraham JacobTucson$21K
- Deborah XiePhoenix$7K
- Thomas KangOro Valley$6K
- Mark SymsPhoenix$4K
- Peter WeisskopfScottsdale$3K
- Samuel BarberPhoenix$3K
- John MaciasPhoenix$480
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.